Neural Zoomer Plus

What is the Neural Zoomer Plus Test?

The Neural Zoomer Plus Test from Vibrant Wellness has been designed to assess the reactivity to 48 neurological antigens connected to various neurologically related diseases. The analysis of the most well-studied neurological autoantibodies allow physicians to select treatment protocols by unmasking the mechanisms behind disease progression.

This test aims to reduce the prevalence of neurological conditions by providing both patients and physicians with a crucial methodology for early risk detection and primary prevention.

The optional additional genetic testing for the ApoE genotype is available with the Neural Zoomer Plus Test. The ApoE genotype has been shown to influence risk for specific neurological conditions.

By selecting this test, physicians apply the most advanced and relevant test available to evaluate the presence and risk of neurological autoimmunity.

The test represents the most comprehensive and compelling scientific data identifying autoantibodies associated with a range of neurological disorders, allowing early risk detection and prevention of neurodegeneration.

Which Patients is the Neural Zoomer Plus Test Best Used For?

There are several symptoms associated with autoimmunity in the nervous
system: cognitive decline, memory loss, ataxia, balance problems, neuropathy, Alzheimer’s disease, multiple sclerosis, encephalitis, muscle spasms, Huntington’s disease, epilepsy, Parkinson’s disease, dementia, Myasthenia Gravis, Muscle stiffness/rigidity, optical decline, neuromyelitis optica, previous history of concussion, autism, PANDAS/ANDAS/OCD, and demyelinating diseases.

What Does Neural Zoomer Plus Test Measure?

The Neural Zoomer Plus Test evaluates a comprehensive list of autoimmune markers such as antigens involved in:

• Demyelination (anti-tubulin, anti-myelin essential protein, anti-myelin oligodendrocyte, and others)
• Blood Brain Barrier Disruption (Anti-Glial fibrillary acidic protein, Anti-Microglia, and others)
• Optical and Autonomic Nervous System Disorders (Anti-Neuron specific enolase, Anti-Aquaporin 4, and others)
• Peripheral Neuropathy (Anti-GM1, Anti-GM2, anti-Hu, Anti-Ri, and Anti- Amphiphysin)
• Neuromuscular disorders (Anti-Acetylcholine receptors, Anti-Voltage gated calcium channels, Anti-Muscle specific kinase, and others)
• Brain Autoimmunity (Anti-Purkinje cell, Anti-Amyloid beta, Anti-Alpha-synuclein, Anti-α1, and β2 adrenergic receptors, and others)
• Brain Inflammation (Anti-NMDA receptor, Anti-Dopamine receptors, Anti- GABA receptors, Anti-Glycine receptor, and others)
• Infections (Anti-HSV-1, Anti-HSV-2, Anti-Streptococcal A, and others).

The test results of the antibody levels evaluated are calculated by comparing the average intensity of the individual protein antibody of each protein in a healthy reference population of 192 individuals.

What Type of Sample is Needed?

This is a serum based test and requires phlebotomy. This test cannot be ordered for patients under 2 years of age.